{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:48:52Z","timestamp":1789858132278,"version":"4.0.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1136\/ard.2007.087593","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T00:55:31Z","timestamp":1208307331000},"page":"519-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry"],"prefix":"10.1016","volume":"68","author":[{"given":"G","family":"Horneff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"De Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Foeldvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H J","family":"Girschick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Moebius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Schmeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.2007.087593_bib1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0140-6736(05)60640-X","article-title":"Juvenile chronic arthritis.","volume":"351","author":"Woo","year":"1998","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1136\/ard.2007.087593_bib2","first-page":"195","article-title":"Current proposed revision of JRA criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation.","volume":"20","author":"Brewer","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.087593_bib3","first-page":"390","article-title":"International League of Associations for Rheumatology. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.087593_bib4","first-page":"1377","article-title":"Epidemiology of juvenile idiopathic arthritis in Alsace, France.","volume":"33","author":"Danner","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.087593_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1093\/rheumatology\/38.8.739","article-title":"Prognosis in children with rheumatic diseases: justification for consideration of new therapies.","volume":"38","author":"Petty","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.087593_bib6","first-page":"2256","article-title":"Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy.","volume":"27","author":"Minden","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.087593_bib7","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJM199204163261602","article-title":"Methotrexate in resistant juvenile rheumatoid arthritis. Results of the USA\u2013USSR double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children\u2019s Study Group.","volume":"326","author":"Giannini","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.087593_bib8","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM200003163421103","article-title":"Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group.","volume":"342","author":"Lovell","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2007.087593_bib9","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/art.21885","article-title":"Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis.","volume":"54","author":"Lovell","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.087593_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s003930070043","article-title":"Empfehlungen der Arbeitsgemeinschaft Kinder \u2013 und Jugendrheumatologie zur Therapie mit Etanercept (P75 TNF-Rezeptor- Immunglobulinfusionsprotein).","volume":"59","author":"Horneff","year":"2001","journal-title":"Z Rheumatol"},{"key":"10.1136\/ard.2007.087593_bib11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","article-title":"Paediatric Rheumatology Collaborative Group: The German Etanercept Registry for treatment of juvenile idiopathic arthritis.","volume":"63","author":"Horneff","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.087593_bib12","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1002\/art.22121","article-title":"Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al.","volume":"54","author":"Yazici","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.087593_bib13","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1002\/art.21830","volume":"54","author":"Hyrich","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"Suppl 23","key":"10.1136\/ard.2007.087593_bib14","first-page":"71","article-title":"The German version of the Childhood Health Assessment Questionaire (CHAQ) and the Child Health Questionaire.","volume":"19","author":"Foeldvari","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2007.087593_bib15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R","article-title":"Preliminary definition of improvement in juvenile arthritis.","volume":"40","author":"Giannini","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.087593_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/ard.57.1.38","article-title":"Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group.","volume":"57","author":"Ruperto","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2007.087593_bib17","first-page":"1186","article-title":"Radiologic improvement of juvenile idiopathic arthritis-enthesitis-related arthritis following anti-tumor necrosis factor-alpha blockade with etanercept.","volume":"33","author":"Tse","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.087593_bib18","first-page":"2055","article-title":"Prolonged efficacy of etanercept in refractory enthesitis-related arthritis.","volume":"31","author":"Henrickson","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2007.087593_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type.","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.087593_bib20","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2007.087593_bib21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/rheumatology\/keh658","article-title":"Etanercept and uveitis in patients with juvenile idiopathic arthritis.","volume":"44","author":"Schmeling","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2007.087593_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/art.20904","article-title":"A randomised, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis.","volume":"53","author":"Smith","year":"2005","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724425569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2007.087593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:08:51Z","timestamp":1736140131000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724425569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0003496724425569"],"URL":"https:\/\/doi.org\/10.1136\/ard.2007.087593","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2007.087593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 2009 Published by Elsevier Inc. Publishing Group and European League Against Rheumatism. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}